Enteral Nutrition Market is expected to reach US$ 17,330.87 Million by 2031

Adult Age Group to Account for Largest Share in Enteral Nutrition Market During 2024–2031

According to our new research study on "Enteral Nutrition Market Forecast to 2031 – Global Analysis – by Product Type, Application, Age Group, Distribution Channel, and Geography," the market was valued at US$ 10,584.80 million in 2024 and is projected to reach US$ 17,330.87 million by 2031; it is expected to register a CAGR of 7.3% during 2025–2031. The increasing prevalence of gastrointestinal diseases, and the rising cases of malnutrition and premature births are contributing to the growing enteral nutrition market size. However, complications associated with the feeding systems hamper the market growth. Further, the development of plant-based nutrition products is expected to bring in new enteral nutrition market trends in the coming years. 

Specific Formulations and Plant-Based Nutrition Products Bolsters Enteral Nutrition Market Growth

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Functionality and specific formulations of enteral products do not interfere with the existing treatments of patients. The macronutrient and micronutrient formulations of enteral nutrition and their applications vary based on the disease under consideration. Isocaloric enteral nutrition formulation (1 kcal/ml) is generally prescribed to achieve estimated or measured caloric goals, while energy-dense formulae (>1 kcal/ml) are prescribed to aid in calorie intake in patients with gastrointestinal dysfunction.

Enteral Nutrition Market Share, by Region, 2024 (%)

Source: The Insight Partners Analysis

A surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are becoming increasingly intolerant of artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. Abbott states that consumers and patients relying on tubes also consider plant-based alternatives for the above-listed reasons. The American Medical Association is calling on healthcare facilities to introduce plant-based meal options to improve patients' health. California, New York, and the District of Columbia, among others, ask hospitals to make healthy, plant-based meals available to all patients. Similarly, companies in Europe are capitalizing on the growing preference for healthy foods in various demographic groups. Kate Farms, Functional Formularies, and Real Food Blends, among others, have developed more natural, plant-based enteral products. In August 2021, Kate Farms launched the first closed feeding system delivering plant-based formulas in ready-to-hang bags of 1 L capacity. Kate Farms Standard 1.4 plain and Peptide 1.5 plain formulations are plant-based, organic, calorically dense products that are used as a sole source of supplemental nutrition in tube feeding. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults. Therefore, functional, patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral nutrition market.

Enteral Nutrition Market Report Scope

The enteral nutrition market has been analyzed by considering the following segments: product type, application, age group, distribution channel, and geography. By age group, the market is bifurcated into adult and pediatric. The adult segment held a larger share of the enteral nutrition market in 2024. A standard tube-feeding formula is designed for adults who have regular digestion. They also contain added ingredients such as fibers for better digestive health and bowel management. Similar to standard formulas, peptide formulas are nutritionally complete. On the other hand, unlike standard formulas, some components of peptide formulas, such as proteins, are broken down into smaller components to make them easier to digest and absorb. Easy digestibility and absorption highlight the suitability of peptide formulas in adults with digestive problems, including short bowel syndrome, inflammatory bowel disease, malabsorption, and cystic fibrosis. Specialized disease-specific enteral formulas are available for adults with special nutritional needs, such as those suffering from diabetes, kidney failure, respiratory disease, or liver disorders. The main ingredients of medical nutritional formulas are lipid emulsions, dextrose, amino acids, vitamins, electrolytes, minerals, and trace elements. These active ingredients help prevent villous atrophy and promote the local immune function of the gut. For example, Elecare by Ross is one of the tube-feeding formulas approved for adults. It is indicated for the dietary management of protein maldigestion, malabsorption, severe food allergies, short-bowel syndrome, and eosinophilic GI disorders, among others.

Nestlé, Danone S.A., Abbott Laboratories, FrieslandCampina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schär AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, and Nutritional Medicinals, LLC are among the leading companies operating in the enteral nutrition market.

Companies operating in the enteral nutrition market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies adopted by many market players. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall enteral nutrition market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

Enteral Nutrition Market Share Analysis: Based on Geography

The scope of the Global enteral nutrition market report includes the assessment of the market performance in the North America, Europe, Asia- Pacific, Middle East and Africa, South and Central America. The North America enteral nutrition market is segmented into the US, Canada, and Mexico.

The geographic scope of the enteral nutrition market includes the assessment of the market performance in North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), South & Central America (Brazil, Argentina, and Rest of South & Central America), and the Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa).   

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com